Targeting galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy

Nikolaos G. Frangogiannis

doi:10.1093/cvr/cvad156

Targeting galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy

Nikolaos G. Frangogiannis

Medicine

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2495-2496
Number of pages	2
Journal	Cardiovascular research
Volume	119
Issue number	15
DOIs	https://doi.org/10.1093/cvr/cvad156
State	Published - Nov 1 2023

ASJC Scopus subject areas

General Medicine

Access to Document

10.1093/cvr/cvad156

Cite this

@article{d7b6181252244a308afa420d6767a999,

title = "Targeting galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy",

author = "Frangogiannis, {Nikolaos G.}",

year = "2023",

month = nov,

day = "1",

doi = "10.1093/cvr/cvad156",

language = "English (US)",

volume = "119",

pages = "2495--2496",

journal = "Cardiovascular research",

issn = "0008-6363",

publisher = "Oxford University Press",

number = "15",

}

TY - JOUR

T1 - Targeting galectin-3 in myocardial infarction

T2 - a unique opportunity for biomarker-guided therapy

AU - Frangogiannis, Nikolaos G.

PY - 2023/11/1

Y1 - 2023/11/1

UR - http://www.scopus.com/inward/record.url?scp=85177976569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85177976569&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvad156

DO - 10.1093/cvr/cvad156

M3 - Editorial

C2 - 37772841

AN - SCOPUS:85177976569

SN - 0008-6363

VL - 119

SP - 2495

EP - 2496

JO - Cardiovascular research

JF - Cardiovascular research

IS - 15

ER -

Targeting galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this